PIK3CA and prostate carcinoma: Furthermore, the pro-inflammatory arachidonic acid-derived prostaglandin E2 (PGE2) was shown to enhance the expression of the bone metastasis-promoting proteins MMP2, MMP9, RANKL, and RUNX2 in prostate cancer cells, partly via the PI3K/AKT pathway [118].